Did OBLN stock beat earnings estimates in the most recent quarter?
Obalon Therapeutics Inc (OBLN) missed EPS estimates and missed revenue estimates in the most recent quarter.
NASDAQ:OBLN
Past quarterly earnings results for Obalon Therapeutics Inc (OBLN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in ): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2021 | -0.44 | - | 78.43% | - | - | |||
| Q4 2020 | -0.51 | -0.18 | -177.78% | - | - | - | ||
| Q3 2020 | -0.60 | -0.21 | -180.11% | - | - | - | ||
| Q2 2020 | -1.62 | -0.92 | -76.47% | - | - | - | ||
| Q1 2020 | -2.04 | -1.56 | -30.72% | - | 710.499K | - | - |
Notes
Obalon Therapeutics Inc (OBLN) missed EPS estimates and missed revenue estimates in the most recent quarter.